Diagnostic Orders Direct
Longevity Screening

Longevity Screening Order Review

Longevity-focused patients pursuing proactive imaging need an honest provider review — not a rubber stamp. Our $40 virtual consultation provides evidence-based assessment of which longevity imaging studies may be medically appropriate for your individual risk profile.

Start Virtual Consult — $40

Evidence-based assessment. Orders issued only when medically appropriate. Not affiliated with any longevity imaging center.

Not all longevity imaging is supported by the same level of evidence. Some studies have strong guideline support; others are investigational or carry significant incidental finding risks. Our provider review provides honest context — not marketing claims.

Longevity Imaging: What the Evidence Shows

Strong Evidence Base

  • LDCT lung screening — Annual low-dose CT for adults 50–80 with ≥20 pack-year smoking history (USPSTF Grade B)
  • Mammography — Biennial screening for women 40–74 (USPSTF; ACS recommends annually starting at 40)
  • Colorectal cancer screening — Colonoscopy, stool-based tests per age/risk guidelines
  • AAA ultrasound — One-time screening for men 65–75 with smoking history (USPSTF Grade B)

Evidence-Based in Specific Risk Groups

  • CAC scoring — For intermediate-risk patients (10-year ASCVD 7.5–20%) where results change management
  • Breast MRI — For BRCA1/2 or high-risk patients (lifetime risk >20%) per ACS guidelines
  • CCTA — For specific cardiovascular diagnostic situations; growing evidence in intermediate risk
  • DEXA bone density — For women ≥65, men ≥70, or younger patients with osteoporosis risk factors

Limited or Emerging Evidence — Use With Caution

  • Whole-body MRI — ACR does not endorse for general population screening; high incidental finding rate
  • CCTA for low-risk asymptomatic patients — Benefit uncertain; radiation and contrast risk present
  • Thyroid ultrasound — Not recommended for asymptomatic patients without risk factors (USPSTF Grade D)
  • Brain MRI screening — Not recommended for asymptomatic general population by ACR

Frequently Asked Questions

Get an Evidence-Based Longevity Imaging Review

$40 virtual consultation. Honest evidence-based assessment. Orders issued only when medically appropriate. Not affiliated with any longevity imaging center.

Start Virtual Consult — $40

Diagnostic Orders Direct does not perform scans, interpret results, or replace ongoing primary or specialty care. Not affiliated with SimonMed, Prenuvo, Ezra, or any imaging center.

We use cookies to improve your experience. By continuing, you consent to our Terms & Conditions.